Muutke küpsiste eelistusi

E-raamat: Immunotherapy for Solid Tumors, An Issue of Surgical Oncology Clinics of North America: Immunotherapy for Solid Tumors, An Issue of Surgical Oncology Clinics of North America, E-Book

Edited by (Associate Professor of Surgery)
  • Formaat: EPUB+DRM
  • Sari: Clinics: Surgery 35
  • Ilmumisaeg: 30-Mar-2026
  • Kirjastus: Elsevier
  • Keel: eng
  • ISBN-13: 9780443428449
Teised raamatud teemal:
  • Formaat - EPUB+DRM
  • Hind: 80,59 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
Immunotherapy for Solid Tumors, An Issue of Surgical Oncology Clinics of North America: Immunotherapy for Solid Tumors, An Issue of Surgical Oncology Clinics of North America, E-Book
  • Formaat: EPUB+DRM
  • Sari: Clinics: Surgery 35
  • Ilmumisaeg: 30-Mar-2026
  • Kirjastus: Elsevier
  • Keel: eng
  • ISBN-13: 9780443428449
Teised raamatud teemal:

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

In this issue of Surgical Oncology Clinics, guest editor Dr. Jashodeep Datta brings his considerable expertise to the topic of Immunotherapy for Solid Tumors. Immunotherapy for solid tumors represents a transformative approach in the field of oncology, and has potential to offer durable responses and long-term remission, even in cancers that have been resistant to conventional therapies. This issue provides a contemporary appraisal of advances in immunotherapy technologies and applications for solid tumors, particularly as they related to the surgical management of these diseases. - Contains 14 relevant, practice-oriented topics including the innovative use of circulating tumor DNA as a biomarker to decipher immunotherapy responses; TCR-engineered T cell therapies for solid tumors; new innovations in CAR-T cell approaches; combining systemic and local/regional approaches to improve immunotherapy sensitivity; mRNA vaccines for cancer treatment; management of immunotherapy toxicities; and more- Provides in-depth clinical reviews on immunotherapy for solid tumors, offering actionable insights for clinical practice- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews